A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis)
Journal name: AYU (Journal of Research in Ayurveda)
Original article title: A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis)
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Mayuri R. Shah
Charmi S. Mehta
V. D. Shukla
Alankruta R. Dave
N. N. Bhatt
Download the PDF file of the original publication
AYU (Journal of Research in Ayurveda):
(An International Quarterly Journal of Research in Ayurveda)
Full text available for: A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis)
Year: 2010 | Doi: 10.4103/0974-8520.72399
Copyright (license): CC BY-NC-SA 4.0
Summary of article contents:
Sandhigatavata is described under vatavyadhi in all ayurvedic classical texts. Osteoarthritis is the most common articular disorder which begins asymptomatically in the second and third decades and is extremely common by age 70. Here Matra Vasti (therapeutic enema) was given with Bala taila as Vasti is the best treatment for vatavyadhies. It has vatashamaka and rasayana properties. Indigenous compound drug containing Guggulu, Shallaki, Yastimadhu, Pippali, Guduchi, Nirgundi, Kupilu and Godanti was given in one group along with Matra Vasti. In this study, 33 patients of Sandhigatavata completed the treatment. Patients were randomly divided into two groups. Sixteen patients in Group-A (sarvanga Abhyanga-swedana + matravasti) and 17 patients in Group-B (sarvanga Abhyanga–swedana+ matravasti + indigenous compound drug). The results of the study indicate that the patients of both the groups obtained highly significant relief in almost all the signs and symptoms of Sandhigatavata. Keywords: Abhyanga, indigenous compound drug, Matra Vasti, osteoarthritis, Sandhigatavata, swedana, vatavyadhi, therapeutic enema.
Other Health Sciences Concepts:
Discover the significance of concepts within the article: ‘A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis)’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:
Abhyanga, Snehana, Matravasti, Balataila, Therapeutic enema, Group A, Group (b), Age-group, Clinical trial, Osteoarthritis, Swedana, Sandhigatavata, Indigenous compound drug, Pain during flexion, Joint effusion, Musculoskeletal problem, X-ray examination, Cardinal symptom.